1-4 of 4
J Matthews
Close
Sort by
Journal Articles

Preclinical Characterization of PWT143, a Novel Selective and Potent Phosphatidylinositol 3-kinase Delta (PI3K delta) Inhibitor with Ex-Vivo Activity in Hematologic Malignancies.

Marie O'Farrell, PhD, Richard Ventura, Albert Tai, Jeffrey W Tyner, PhD, Marc M Loriaux, MD, PhD, Daruka Mahadevan, MD, PhD, Carla Morales, S. David Brown, David J Matthews, PhD
Journal: Blood
Blood (2012) 120 (21): 2907.
https://doi.org/10.1182/blood.V120.21.2907.2907
Published: 2012
Journal Articles

Preliminary Results of a Phase I/II Study of Weekly or Twice Weekly Bortezomib in Combination with Rituximab, in Patients with Follicular Lymphoma, Mantle Cell Lymphoma and Waldenström’s Macroglobulinaemia.

A. Agathocleous, S. Rule, P. Johnson, J.A. Radford, N. Lafon, H. Hunter, J.P. Kerr, S.M. Neeson, J. Matthews, S. Strauss, S. Montoto, A.Z.S. Rohatiner, T.A. Lister
Journal: Blood
Blood (2007) 110 (11): 2559.
https://doi.org/10.1182/blood.V110.11.2559.2559
Published: 2007
Journal Articles

Homodimerization of Erythropoietin Receptor by a Bivalent Monoclonal Antibody Triggers Cell Proliferation and Differentiation of Erythroid Precursors

Helmut Schneider, Warak Chaovapong, David J. Matthews, Cyrus Karkaria, Robert T. Cass, Hangjun Zhan, Mark Boyle, Tony Lorenzini, Steve G. Elliott, Lutz B. Giebel
Journal: Blood
Blood (1997) 89 (2): 473–482.
https://doi.org/10.1182/blood.V89.2.473
Published: 1997
Journal Articles

Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group

K Bradstock, J Matthews, E Benson, F Page, J Bishop
Journal: Blood
Blood (1994) 84 (4): 1220–1225.
https://doi.org/10.1182/blood.V84.4.1220.1220
Published: 1994